Osimertinib for an Advanced NSCLC Patient with Two Common EGFR Mutations and a Concomitant MET Exon 14 Skipping Mutation: A Case Report

Liu Z, Song P, Zhou L, Ji D, Shen H, Dong H, Feng X

Cancer Management and Research 2023, 15:645-650

Published Date: 12 July 2023